Alzheimer's treatment built on Sarasota research heads toward FDA approval

Sarasota's Roskamp Institute was the first to discover a protein that tends to form clumps in the brains of people with Alzheimer's. A new drug has been shown to reduce it.

Related Keywords

, Roskamp Institute , Alzheimer Association , Drug Administration , Sarasota Roskamp Institute , Michael Mullen , Executive Director ,